Literature DB >> 16439601

Mutations in the Wilms' tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9.

Bettina Mucha1, Fatih Ozaltin, Bernward G Hinkes, Katrin Hasselbacher, Rainer G Ruf, Michael Schultheiss, Daniela Hangan, Bethan E Hoskins, Anne Schulze Everding, Radovan Bogdanovic, Thomas Seeman, Bernd Hoppe, Friedhelm Hildebrandt.   

Abstract

Primary steroid-resistant nephrotic syndrome (SRNS) is characterized by childhood onset of proteinuria and progression to end-stage renal disease. Approximately 10-25% of familial and sporadic cases are caused by mutations in NPHS2 (podocin). Mutations in exons 8 and 9 of the WT1 gene have been found in patients with isolated SRNS and in SRNS associated with Wilms' tumor (WT) or urogenital malformations. However, no large studies have been performed to date to examine whether WT1 mutations in isolated SRNS are restricted to exons 8 and 9. To address this question, we screened a worldwide cohort of 164 cases of sporadic SRNS for mutations in all 10 exons of the WT1 gene by multiplex capillary heteroduplex analysis and direct sequencing. NPHS2 mutations had been excluded by direct sequencing. Fifteen patients exhibited seven different mutations exclusively in exons 8 and 9 of WT1. Although it is possible that pathogenic mutations of WT1 may also reside in the introns, regions of the gene that were not able to be screened in this study, these data together with our previous results (Ruf et al.: Kidney Int 66: 564-570, 2004) indicate that screening of WT1 exons 8 and 9 in patients with sporadic SRNS is sufficient to detect pathogenic WT1 mutations and may open inroads into differential therapy of SRNS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439601     DOI: 10.1203/01.pdr.0000196717.94518.f0

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  62 in total

1.  Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome.

Authors:  Eduardo Machuca; Geneviève Benoit; Fabien Nevo; Marie-Josèphe Tête; Olivier Gribouval; Audrey Pawtowski; Per Brandström; Chantal Loirat; Patrick Niaudet; Marie-Claire Gubler; Corinne Antignac
Journal:  J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 10.121

2.  Genetic abnormalities and prognosis in patients with congenital and infantile nephrotic syndrome.

Authors:  Onur Cil; Nesrin Besbas; Ali Duzova; Rezan Topaloglu; Amira Peco-Antić; Emine Korkmaz; Fatih Ozaltin
Journal:  Pediatr Nephrol       Date:  2015-02-27       Impact factor: 3.714

3.  Broad and unexpected phenotypic expression in Greek children with steroid-resistant nephrotic syndrome due to mutations in the Wilms' tumor 1 (WT1) gene.

Authors:  Spyridon Megremis; Andromachi Mitsioni; Irene Fylaktou; Sofia Kitsiou Tzeli; Filadelfia Komianou; Constantinos J Stefanidis; Emmanuel Kanavakis; Joanne Traeger-Synodinos
Journal:  Eur J Pediatr       Date:  2011-04-16       Impact factor: 3.183

4.  MYO1E mutations and childhood familial focal segmental glomerulosclerosis.

Authors:  Caterina Mele; Paraskevas Iatropoulos; Roberta Donadelli; Andrea Calabria; Ramona Maranta; Paola Cassis; Simona Buelli; Susanna Tomasoni; Rossella Piras; Mira Krendel; Serena Bettoni; Marina Morigi; Massimo Delledonne; Carmine Pecoraro; Isabella Abbate; Maria Rosaria Capobianchi; Friedhelm Hildebrandt; Edgar Otto; Franz Schaefer; Fabio Macciardi; Fatih Ozaltin; Sevinc Emre; Tulin Ibsirlioglu; Ariela Benigni; Giuseppe Remuzzi; Marina Noris
Journal:  N Engl J Med       Date:  2011-07-14       Impact factor: 91.245

5.  Retrospective mutational analysis of NPHS1, NPHS2, WT1 and LAMB2 in children with steroid-resistant focal segmental glomerulosclerosis - a single-centre experience.

Authors:  Agnieszka Bińczak-Kuleta; Jacek Rubik; Mieczysław Litwin; Małgorzata Ryder; Klaudyna Lewandowska; Olga Taryma-Leśniak; Jeremy S Clark; Ryszard Grenda; Andrzej Ciechanowicz
Journal:  Bosn J Basic Med Sci       Date:  2014-05       Impact factor: 3.363

6.  NPHS2 screening with SURVEYOR in Hellenic children with steroid-resistant nephrotic syndrome.

Authors:  Konstantinos Voskarides; Christiana Makariou; Gregory Papagregoriou; Nicolaos Stergiou; Nicoletta Printza; Efstathios Alexopoulos; Avraam Elia; Fotis Papachristou; Alkis Pierides; Eleni Georgaki; Constantinos Deltas
Journal:  Pediatr Nephrol       Date:  2008-04-05       Impact factor: 3.714

7.  Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor.

Authors:  Jane Lange; Susan M Peterson; Janice R Takashima; Yevgeny Grigoriev; Michael L Ritchey; Robert C Shamberger; J Bruce Beckwith; Elizabeth Perlman; Daniel M Green; Norman E Breslow
Journal:  J Urol       Date:  2011-06-17       Impact factor: 7.450

Review 8.  Genetic testing for kidney disease of unknown etiology.

Authors:  Thomas Hays; Emily E Groopman; Ali G Gharavi
Journal:  Kidney Int       Date:  2020-04-24       Impact factor: 10.612

9.  Complete remission of nephrotic syndrome in an infant with focal segmental glomerulosclerosis: is it renin-angiotensin blockade?

Authors:  Neveen A Soliman; Magdi Francis; Saskia F Heeringa; Gil Chernin
Journal:  Pediatr Nephrol       Date:  2008-10-14       Impact factor: 3.714

10.  NPHS2 p.V290M mutation in late-onset steroid-resistant nephrotic syndrome.

Authors:  Andrea Kerti; Rózsa Csohány; Attila Szabó; Ottó Arkossy; Péter Sallay; Vincent Moriniére; Virginia Vega-Warner; Gábor Nyírő; Orsolya Lakatos; Tamás Szabó; Beata S Lipska; Franz Schaefer; Corinne Antignac; George Reusz; Tivadar Tulassay; Kálmán Tory
Journal:  Pediatr Nephrol       Date:  2012-12-14       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.